Cargando…

Thiopurines are an independent risk factor for active tuberculosis in inflammatory bowel disease patients

The use of thiopurines is an independent risk factor for active tuberculosis in patients with inflammatory bowel disease.

Detalles Bibliográficos
Autores principales:	Fortes, Flora Maria Lorenzo, Rocha, Raquel, Santana, Genoile Oliveira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044854/ https://www.ncbi.nlm.nih.gov/pubmed/36998430 http://dx.doi.org/10.3748/wjg.v29.i9.1536

Ejemplares similares

Nodular regenerative hyperplasia in inflammatory bowel disease patients with allopurinol–thiopurine cotherapy
por: Simsek, Melek, et al.
Publicado: (2018)

Thiopurine Methyltransferase Activity and Thiopurine Metabolites in Inflammatory Bowel Disease
por: El-Matary, Wael
Publicado: (2020)

Influence of nutritional status in the postoperative period of patients with inflammatory bowel disease
por: Rocha, Raquel, et al.
Publicado: (2021)

Active tuberculosis in inflammatory bowel disease patients under treatment from an endemic area in Latin America
por: Fortes, Flora Maria Lorenzo, et al.
Publicado: (2020)

Thiopurines in Inflammatory Bowel Disease. How to Optimize Thiopurines in the Biologic Era?
por: Gargallo-Puyuelo, Carla J., et al.
Publicado: (2021)

Thiopurine methyltransferase genotype and thiopurine S-methyltransferase activity in Greek children with inflammatory bowel disease
por: Gazouli, Μaria, et al.
Publicado: (2012)

What nutritional factors influence bone mineral density in Crohn's disease patients?
por: Gomes Coqueiro, Fernanda, et al.
Publicado: (2018)

Use of thiopurines in inflammatory bowel disease: an update
por: Singh, Arshdeep, et al.
Publicado: (2022)

Nutritional status as a predictor of hospitalization in inflammatory bowel disease: A review
por: Rocha, Raquel, et al.
Publicado: (2019)

Thiopurine S-Methyltransferase and Methylenetetrahydrofolate Reductase Polymorphisms in Leukemia
por: KÜPELİ, Serhan
Publicado: (2015)

Cytotoxicity of Thiopurine Drugs in Patients with Inflammatory Bowel Disease
por: Zakerska-Banaszak, Oliwia, et al.
Publicado: (2022)

Nutritional impact of inflammatory bowel diseases on children and adolescents
por: dos Santos, Gilton Marques, et al.
Publicado: (2014)

Thiopurine metabolite level and toxicity in Indians with inflammatory bowel disease
por: Parkar, Suruchi P, et al.
Publicado: (2017)

Biomarkers Predictive of Response to Thiopurine Therapy in Inflammatory Bowel Disease
por: Cornish, Jack S., et al.
Publicado: (2020)

Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases
por: Tominaga, Keiichi, et al.
Publicado: (2021)

Safety and Efficacy of Split-Dose Thiopurine vs Low-Dose Thiopurine-Allopurinol Cotherapy in Pediatric Inflammatory Bowel Disease
por: Cococcioni, Lucia, et al.
Publicado: (2022)

Xanthine oxidase activity in thiopurine curative Chinese inflammatory bowel disease patients
por: Ding, Liang, et al.
Publicado: (2021)

Monitoring Thiopurine Metabolites in Korean Pediatric Patients with Inflammatory Bowel Disease
por: Kim, Mi Jin, et al.
Publicado: (2014)

Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective
por: Axelrad, Jordan E, et al.
Publicado: (2016)

How I treat my inflammatory bowel disease-patients with thiopurines?
por: Meijer, Berrie, et al.
Publicado: (2016)

Can We Predict the Toxicity and Response to Thiopurines in Inflammatory Bowel Diseases?
por: Luber, Raphael P., et al.
Publicado: (2019)

Frequency of Hepatobiliary Manifestations and Concomitant Liver Disease in Inflammatory Bowel Disease Patients
por: Silva, Juliana, et al.
Publicado: (2019)

Risk factors for thiopurine‐induced myelosuppression and infections in inflammatory bowel disease patients with a normal TPMT genotype
por: Broekman, M. M. T. J., et al.
Publicado: (2017)

Use of Thiopurines and Risk of Colorectal Neoplasia in Patients with Inflammatory Bowel Diseases: A Meta-Analysis
por: Gong, Jianfeng, et al.
Publicado: (2013)

Association between Thiopurine S-methyltransferase Polymorphisms and Thiopurine-Induced Adverse Drug Reactions in Patients with Inflammatory Bowel Disease: A Meta-Analysis
por: Liu, Yue-Ping, et al.
Publicado: (2015)

Analytical Pitfalls of Therapeutic Drug Monitoring of Thiopurines in Patients With Inflammatory Bowel Disease
por: Simsek, Melek, et al.
Publicado: (2017)

Inflammatory Bowel Disease and the Risk of Herpes Zoster
por: Lai, Shih-Wei
Publicado: (2019)

Impact of thiopurine dose in anti-tumor necrosis factor combination therapy on outcomes in inflammatory bowel disease
por: Nawaz, Ahmad, et al.
Publicado: (2023)

Impact of inflammatory bowel disease activity and thiopurine therapy on birth weight: A meta-analysis
por: Gonzalez-Suarez, Begoña, et al.
Publicado: (2017)

The effects of thiopurine therapy on health-related quality of life in Inflammatory Bowel Disease patients
por: Bastida, Guillermo, et al.
Publicado: (2010)

Rac Attack: Modulation of the Small GTPase Rac in Inflammatory Bowel Disease and Thiopurine Therapy
por: Seinen, Margien L., et al.
Publicado: (2016)

The impact of thiopurines on surgical outcomes in inflammatory bowel disease: do they make a difference?
por: Chhaya, Vivek, et al.
Publicado: (2013)

Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients
por: Ribaldone, Davide Giuseppe, et al.
Publicado: (2019)

Thiopurine use associated with reduced B and natural killer cells in inflammatory bowel disease
por: Lord, James D, et al.
Publicado: (2017)

Thiopurine S-methyltransferase genetic polymorphisms in adult patients with inflammatory bowel diseases in the Latvian population
por: Zalizko, Polina, et al.
Publicado: (2020)

NUDT15 gene variants and thiopurine-induced leukopenia in patients with inflammatory bowel disease
por: Matsuoka, Katsuyoshi
Publicado: (2020)

Feasibility of Reduced Clinical Monitoring in Patients with Inflammatory Bowel Disease Treated with Thiopurine Therapy
por: Jansen, Fenna M., et al.
Publicado: (2023)

Crohn’s disease of esophagus, stomach and duodenum
por: Pimentel, Andréa Maia, et al.
Publicado: (2019)

Tuberculin skin testing in inflammatory bowel disease patients from an endemic area of Brazil
por: Cardoso, Ingrid Puig, et al.
Publicado: (2013)

Tremor in Patients with Inflammatory Bowel Disease
por: De Oliveira, Gisele R., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_0rv7dm1g4n9770a7lu71kcqei6